ATC code D03
(Redirected from Cicatrizant)
| ATC code D: Dermatologicals |
|---|
|
| ATCvet only |
| Other ATC codes |
ATC code D03 Preparations for treatment of wounds and ulcers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D03 is part of the anatomical group D Dermatologicals.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD03.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
D03A Cicatrizants
[edit]D03AA Cod-liver oil ointments
[edit]D03AX Other cicatrizants
[edit]- D03AX01 Cadexomer iodine
- D03AX02 Dextranomer
- D03AX03 Dexpanthenol
- D03AX04 Calcium pantothenate
- D03AX05 Hyaluronic acid
- D03AX06 Becaplermin
- D03AX09 Crilanomer
- D03AX10 Enoxolone
- D03AX11 Sodium chlorite (tetrachlorodecaoxide)
- D03AX12 Trolamine
- D03AX13 Betulae cortex
- D03AX14 Centella asiatica herba , incl. combinations
- D03AX15 Trafermin
- D03AX16 Beremagene geperpavec
- QD03AX90 Ketanserin
D03B Enzymes
[edit]D03BA Proteolytic enzymes
[edit]- D03BA01 Trypsin
- D03BA02 Clostridiopeptidase
- D03BA03 Bromelains
- D03BA52 Collagenase, combinations
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code D03". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QD03". WHO Collaborating Centre for Drug Statistics Methodology.